---
category: news
title: "Lantern Pharma Announces Positive Preclinical Data in Glioblastoma (GBM) with Drug Candidate LP-184 and Expands GBM Research Collaboration"
excerpt: "Lantern Pharma (NASDAQ:LTRN), a clinical stage biopharmaceutical company, announced today that a successful preclinical"
publishedDateTime: 2021-08-19T12:50:00Z
originalUrl: "https://www.benzinga.com/pressreleases/21/08/n22574787/lantern-pharma-announces-positive-preclinical-data-in-glioblastoma-gbm-with-drug-candidate-lp-184-"
webUrl: "https://www.benzinga.com/pressreleases/21/08/n22574787/lantern-pharma-announces-positive-preclinical-data-in-glioblastoma-gbm-with-drug-candidate-lp-184-"
ampWebUrl: "https://www.benzinga.com/amp/content/22574787"
cdnAmpWebUrl: "https://www-benzinga-com.cdn.ampproject.org/c/s/www.benzinga.com/amp/content/22574787"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - AI in Healthcare
  - AI

secured: "FYoLDd4XK0JKdQy+IGQ5dATI7EksSLerWY1oMcR+X1UR+yAVpFE0s20jB516DEWrVgRCnECZ37FZGZkKK4G795Drx3WgH/r8YFgOdYNcvQJKn7Va0wJ+CzMLwkAANnZC70ADTrYZTc/fh/lzE/IBKu/bxGBAfS2wEo74VVTGkLHaIqiZZ+/7In4bUx2AnMbOR0gnyN8tyC2g69BUF0jHM7HR/iW6sqKTiE7b7GtN9/JSzykah7h47hgdzZ7nGZXJB8EwQGzrWU7Jb+mHySblfnxAf2yMYQDxf2i539hoDsVGJ2RlJGEb0cTLYL115BknY4n1fht2/O0hh1gCxIu+nt2GQbOu7RF2Q3HIOfskwhI=;3ZTx68H1iUm4p9XrTAUfUw=="
---

